Literature DB >> 11739599

Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

P Celada1, M V Puig, J M Casanovas, G Guillazo, F Artigas.   

Abstract

Anatomical evidence indicates that medial prefrontal cortex (mPFC) neurons project to the dorsal raphe nucleus (DR). In this study, we functionally characterized this descending pathway in rat brain. Projection neurons in the mPFC were identified by antidromic stimulation from the DR. Electrical stimulation of the mPFC mainly inhibited the activity of DR 5-HT neurons (55 of 66). Peristimulus time histograms showed a silence of 150 +/- 9 msec poststimulus (latency, 36 +/- 1 msec). The administration of WAY-100635 and picrotoxinin partly reversed this inhibition, indicating the involvement of 5-HT(1A) and GABA(A) receptors. In rats depleted of 5-HT with p-chlorophenylalanine, the electrical stimulation of mPFC mainly activated 5-HT neurons (31 of 40). The excitations (latency, 17 +/- 1 msec) were antagonized by MK-801 and NBQX. Likewise, MK-801 prevented the rise in DR 5-HT release induced by electrical stimulation of mPFC. The application of 8-OH-DPAT in mPFC significantly inhibited the firing rate of DR 5-HT neurons and, in dual-probe microdialysis experiments, reduced the 5-HT output in mPFC and DR. Furthermore, the application of WAY-100635 in mPFC significantly antagonized the reduction of 5-HT release produced by systemic 8-OH-DPAT administration in both areas. These results indicate the existence of a complex regulation of DR 5-HT neurons by mPFC afferents. The stimulus-induced excitation of some 5-HT neurons by descending excitatory fibers releases 5-HT, which inhibits the same or other DR neurons by acting on 5-HT(1A) autoreceptors. Afferents from the mPFC also inhibit 5-HT neurons through the activation of GABAergic interneurons. Ascending serotonergic pathways may control the activity of this descending pathway by acting on postsynaptic 5-HT(1A) receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739599      PMCID: PMC6763042     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

1.  Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.

Authors:  R Tao; Z Ma; S B Auerbach
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

2.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

3.  Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study.

Authors:  M Takagishi; T Chiba
Journal:  Brain Res       Date:  1991-12-06       Impact factor: 3.252

4.  Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients.

Authors:  N C Andreasen; D S O'Leary; M Flaum; P Nopoulos; G L Watkins; L L Boles Ponto; R D Hichwa
Journal:  Lancet       Date:  1997-06-14       Impact factor: 79.321

5.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.

Authors:  E C Azmitia; M Segal
Journal:  J Comp Neurol       Date:  1978-06-01       Impact factor: 3.215

6.  The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.

Authors:  J M Casanovas; M Lésourd; F Artigas
Journal:  Br J Pharmacol       Date:  1997-10       Impact factor: 8.739

7.  Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo.

Authors:  S Murase; J Grenhoff; G Chouvet; F G Gonon; T H Svensson
Journal:  Neurosci Lett       Date:  1993-07-09       Impact factor: 3.046

8.  Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

Authors:  A Adell; F Artigas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

9.  Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin.

Authors:  S R Sesack; A Y Deutch; R H Roth; B S Bunney
Journal:  J Comp Neurol       Date:  1989-12-08       Impact factor: 3.215

10.  The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.

Authors:  H Gozlan; S Thibault; A M Laporte; L Lima; M Hamon
Journal:  Eur J Pharmacol       Date:  1995-01-16       Impact factor: 4.432

View more
  143 in total

1.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.

Authors:  Laia Lladó-Pelfort; Marie-Bernadette Assié; Adrian Newman-Tancredi; Francesc Artigas; Pau Celada
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

Review 3.  Serotonin and prefrontal cortex function: neurons, networks, and circuits.

Authors:  M Victoria Puig; Allan T Gulledge
Journal:  Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.590

4.  Beyond Depression: Towards a Process-Based Approach to Research, Diagnosis, and Treatment.

Authors:  Marie J C Forgeard; Emily A P Haigh; Aaron T Beck; Richard J Davidson; Fritz A Henn; Steven F Maier; Helen S Mayberg; Martin E P Seligman
Journal:  Clin Psychol (New York)       Date:  2011-12

5.  Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.

Authors:  L Lladó-Pelfort; M-B Assié; A Newman-Tancredi; F Artigas; P Celada
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

6.  Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.

Authors:  F R Carreno; J J Donegan; A M Boley; A Shah; M DeGuzman; A Frazer; D J Lodge
Journal:  Mol Psychiatry       Date:  2015-12-01       Impact factor: 15.992

Review 7.  Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

8.  NMDA receptors trigger neurosecretion of 5-HT within dorsal raphe nucleus of the rat in the absence of action potential firing.

Authors:  C P J de Kock; L N Cornelisse; N Burnashev; J C Lodder; A J Timmerman; J J Couey; H D Mansvelder; A B Brussaard
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

9.  Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe.

Authors:  Julia C Lemos; Yu-Zhen Pan; Xiaohong Ma; Christophe Lamy; Adaure C Akanwa; Sheryl G Beck
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

10.  Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides.

Authors:  Maura Boldrini; Mark D Underwood; J John Mann; Victoria Arango
Journal:  J Psychiatr Res       Date:  2007-06-15       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.